Chemistry:Velagliflozin
From HandWiki
Short description: Medication
 | |
| Clinical data | |
|---|---|
| Trade names | Senvelgo |
| License data | |
| Routes of administration | By mouth |
| ATCvet code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C23H25NO5 |
| Molar mass | 395.455 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Velagliflozin, sold under the brand name Senvelgo, is an antidiabetic medication used for the treatment of cats.[1][2] Velagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor.[3] It is taken by mouth.[1]
Medical uses
Velagliflozin is indicated to improve glycemic control in otherwise healthy cats with diabetes not previously treated with insulin.[1][2][3]
References
- ↑ 1.0 1.1 1.2 1.3 "Senvelgo- velagliflozin solution". 8 November 2023. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3ec5ca1f-bded-459e-a813-24d931d50b9a.
- ↑ 2.0 2.1 https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/14320
This article incorporates text from this source, which is in the public domain.
- ↑ 3.0 3.1 "Dear Veterinarian Letter regarding important safety conditions associated with the use of Senvelgo (velagliflozin oral solution) for improving glycemic control in certain cats with diabetes mellitus". 4 December 2023. https://www.fda.gov/animal-veterinary/product-safety-information/dear-veterinarian-letter-regarding-important-safety-conditions-associated-use-senvelgo-velagliflozin. This article incorporates text from this source, which is in the public domain.
 |  |
